Home Tags Cannabidiol

cannabidiol

NPA

NPA Submits Comments to FDA on NDIs and CBD

Washington, DC--The Natural Products Association (NPA) has filed comments with the Food and Drug Administration (FDA) regarding its review of “Responsible Innovation in Dietary...

CBD Industry to Increase 706% Through 2023, Report Predicts

Chicago, IL—A report by Brightfield Group uncovered shifts across the U.S. Cannabidiol (CBD) industry signaling a seven-fold increase in the market, according to a...

5 Ways to Keep Panicky Pets Calm on July 4

Big parties, loud fireworks, louder kids: Fourth of July celebrations, as much fun as they are for us, are stress factories for pets. Fortunately,...

Scientists ID CBD as a “Powerful New Antibiotic”

San Francisco, CA—New research presented at ASM Microbe, the annual meeting of the American Society for Microbiology (ASM), has revealed that cannnabidiol (CBD) is...

Exploring 5 Top Trends in Food Science

New Orleans, LA--Each year, the Institute of Food Technologists (IFT) showcases what's new and what's next in the food industry at its annual event...

House Passes Amendment Designed to Ensure CBD is Regulated by FDA

Washington, DC--The Natural Products Association (NPA) announced earlier this week that it was seeking help from Congress to encourage the Food and Drug Administration...

CRN on DSHEA at 25: The Industry is at a Crossroads

New York, NY—Day one of the 7th Annual Legal, Regulatory and Compliance Forum on Dietary Supplements by the American Conference Institute (ACI) together with...

Plant Based World Expo: “This Is Here to Stay, and Keep Growing”

New York City, NY--The Plant Based World Conference & Expo (PBWCE) was packed—at times, attendees couldn’t make it through the aisles. Plant-based meat was, to...

UNPA and HIA Work to Advance Hemp Extract Research, Safety and Quality Standards

Salt Lake City, UT--In an effort to advance hemp extract product research, safety, identity and quality standards, the United Natural Products Alliance (UNPA) signed...

FDA Cannabis/CBD Public Hearing: “FDA Does Not Have the Luxury Of Time”

Washington, D.C.—The Food and Drug Administration (FDA) held a public hearing on Friday looking for scientific data and information regarding cannabis and cannabis-derived compounds....

BACK ISSUES

MULTIMEDIA